Trump backer busted in Aussie biotech bungle

Outsider/

10 August 2018
| By Outsider |
image
image image
expand image

It would seem that when you’re a US Congressman, sitting down with your son to have “the drug talk” can mean something entirely different to what takes place over a suburban kitchen table.

Instead of the usual speeches of “don’t drink and drive” or “there’s a time and place for doing everything … and it’s called university,” Rep. Christopher Collins of New York allegedly told his son something more along the lines of: “The drug-trial results from this Aussie biotech mob, upon whose board I sit by the way, came back negative. Wanna dump 1.4 million shares?”

According to reports, Collins was arrested on federal charges relating to securities fraud last week in a case involving Australian biotech Innate Immunotherapeutics (try saying that three times, really quickly, under water, with a mouth full of marbles.)

A Securities and Exchange Commission complaint against Collins — the first congressional Republican to endorse Trump’s bid for the White House — also details charges against his son Cameron and the father of his son’s girlfriend, Stephen Zarsky. All three have pleaded not guilty to the charges against them.

The SEC complaint says that in June 2017, Rep. Collins passed on non-public information about Innate Immunotherapeutics’ unexpectedly negative drug-trial results to his son. The case says that Cameron Collins sold nearly 1.4 million shares based on non-public information.

The Collins’s next father-son fishing trip will most likely be postponed.

 

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

So we are now underwriting criminal scams?...

4 months 3 weeks ago

Glad to see the back of you Steve. You made financial more expensive, not more affordable as you claim, and presided ...

4 months 4 weeks ago

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

7 months ago

Commonwealth Bank has formally dropped to zero advisers following LGT Crestone’s acquisition of its advice arm – some six years on from the Hayne royal commission. ...

3 weeks ago

The FSCP has issued a written direction to an adviser who charged clients “extraordinary fees” for inappropriate and conflicted advice, as well as encouraged them to swit...

4 days 2 hours ago

ASIC has cancelled the AFSL of an advice firm associated with Shield and First Guardian collapses, and permanently banned its responsible manager. ...

2 weeks ago

TOP PERFORMING FUNDS

ACS FIXED INT - AUSTRALIA/GLOBAL BOND
Fund name
3y(%)pa
1
DomaCom DFS Mortgage
92.15 3 y p.a(%)
3